227 related articles for article (PubMed ID: 29966535)
21. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
[TBL] [Abstract][Full Text] [Related]
22. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
[TBL] [Abstract][Full Text] [Related]
23. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
[TBL] [Abstract][Full Text] [Related]
24. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
25. The Onchocerciasis Control Programme in West Africa (OCP).
Boatin B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():13-7. PubMed ID: 18718148
[TBL] [Abstract][Full Text] [Related]
26. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
Alley WS; van Oortmarssen GJ; Boatin BA; Nagelkerke NJ; Plaisier AP; Remme JH; Lazdins J; Borsboom GJ; Habbema JD
BMC Public Health; 2001; 1():12. PubMed ID: 11734070
[TBL] [Abstract][Full Text] [Related]
27. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
[TBL] [Abstract][Full Text] [Related]
28. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
Noma M; Zouré HG; Tekle AH; Enyong PA; Nwoke BE; Remme JH
Parasit Vectors; 2014 Jul; 7():325. PubMed ID: 25053266
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Duerr HP; Eichner M
Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
[TBL] [Abstract][Full Text] [Related]
30. Operational Performance of the
Richards FO; Katabarwa M; Bekele F; Tadesse Z; Mohammed A; Sauerbrey M; Dominguez-Vazquez A; Rodriguez-Perez MA; Fernández-Santos NA; Rizzo N; Schuler Martínez HR; Lovato Silva R; Morales Monroy Z; Habomugisha P; Oguttu DW; Zarroug IMA; Aziz NA; Unnasch TR
Am J Trop Med Hyg; 2018 Sep; 99(3):749-752. PubMed ID: 30014821
[TBL] [Abstract][Full Text] [Related]
31. Review of Ethiopian Onchocerciasis Elimination Programme.
Meribo K; Kebede B; Feleke SM; Mengistu B; Mulugeta A; Sileshi M; Samuel A; Deribe K; Tadesse Z
Ethiop Med J; 2017; 55(Suppl 1):55-63. PubMed ID: 28878430
[TBL] [Abstract][Full Text] [Related]
32. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
[TBL] [Abstract][Full Text] [Related]
33. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
Traore MO; Sarr MD; Badji A; Bissan Y; Diawara L; Doumbia K; Goita SF; Konate L; Mounkoro K; Seck AF; Toe L; Toure S; Remme JH
PLoS Negl Trop Dis; 2012; 6(9):e1825. PubMed ID: 23029586
[TBL] [Abstract][Full Text] [Related]
34. Onchocerciasis control in Ghana (1974-2016).
Biritwum NK; de Souza DK; Asiedu O; Marfo B; Amazigo UV; Gyapong JO
Parasit Vectors; 2021 Jan; 14(1):3. PubMed ID: 33388081
[TBL] [Abstract][Full Text] [Related]
35. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
Etya'alé DE
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
[TBL] [Abstract][Full Text] [Related]
36. [Human onchocerciasis in Africa].
Boussinesq M
Med Trop (Mars); 1997; 57(4):389-400. PubMed ID: 9612783
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.
Awadzi K; Opoku NO; Attah SK; Lazdins-Helds JK; Kuesel AC
Parasit Vectors; 2015 Oct; 8():515. PubMed ID: 26452723
[TBL] [Abstract][Full Text] [Related]
38. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
[TBL] [Abstract][Full Text] [Related]
39. [The campaign against onchocerciasis in Africa: update].
Boussinesq M; Hougard JM
Med Trop (Mars); 1998; 58(3):285-96. PubMed ID: 10088109
[TBL] [Abstract][Full Text] [Related]
40. Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
Dolo H; Coulibaly ME; Sow M; Coulibaly YI; Doumbia M; Sangare M; Sanogo A; Dembele B; Guindo B; Coulibaly M; Keita M; Soumaoro L; Diarra D; Dicko B; Hamill L; Doumbia S; Sangho H; Sangare Y; Zhang Y; Tallant J; Yaro AS; Mackenzie C; Nutman TB; Boakye D
PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011632. PubMed ID: 37967137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]